Literature DB >> 1624546

Central nervous system metastases in breast cancer.

I C Kiricuta1, O Kölbl, J Willner, W Bohndorf.   

Abstract

Sixty-two breast cancer patients with central nervous system (CNS) metastases were reviewed. The CNS was the first site of metastatic involvement in 38 cases (61%). The median survival from the primary diagnosis was 3.0 years; from the diagnosis of the CNS metastasis, 6 months. The interval between primary diagnosis and CNS metastasis had a median value of 2.0 years; between the initial extra-cranial metastasis and CNS metastasis this was 0.9 years. Prognostic factors for the appearance of CNS metastasis could not be identified. Subsequent to CNS metastasis appearing, the well-known prognostic factors for the survival time and the metastasis-free interval lose their importance. Brain metastases occur, above all, in patients aged between 50 and 55 years, very often in the first 2.5 years after the first distant metastasis and not later than 10 years from the primary diagnosis.

Entities:  

Mesh:

Year:  1992        PMID: 1624546     DOI: 10.1007/bf01225270

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  4 in total

1.  Central nervous system metastasis from breast carcinoma. Autopsy study.

Authors:  Y Tsukada; A Fouad; J W Pickren; W W Lane
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

2.  The natural history of breast cancer patients with brain metastases.

Authors:  A DiStefano; Y Yong Yap; G N Hortobagyi; G R Blumenschein
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

3.  Proliferative potential of brain metastases.

Authors:  K G Cho; T Hoshino; L H Pitts; K Nomura; Y Shimosato
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

4.  Chemotherapy induces regression of brain metastases in breast carcinoma.

Authors:  D Rosner; T Nemoto; W W Lane
Journal:  Cancer       Date:  1986-08-15       Impact factor: 6.860

  4 in total
  2 in total

1.  Ten years disease-free survival after solitary brain metastasis from breast cancer.

Authors:  C Nieder; K Walter; U Nestle; K Schnabel
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Investigating the causes of vertigo in breast cancer survivors.

Authors:  Zeng-Ming Lin; Yi-Ho Young
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-09-18       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.